Advertisement

Topics

Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines

19:38 EDT 17 May 2018 | Xconomy

An Amgen migraine drug developed to head off pain before it starts has won FDA approval, the first for a new class of preventive drug candidates for the condition. The Amgen (NASDAQ: AMGN) drug, erenumab (Aimovig), is a subcutaneous injection given once a month. The drug blocks the receptor for calcitonin gene-related peptide (CGRP), a […]

Original Article: Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines

NEXT ARTICLE

More From BioPortfolio on "Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...